Metastatic cancer

Common Name(s)

Metastatic cancer

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Metastatic cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Metastatic cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Metastatic cancer" returned 3643 free, full-text research articles on human participants. First 3 results:

Treatment of HER2-positive metastatic breast cancer.
 

Author(s): Sandra M Swain, Emma Clark, José Baselga

Journal: N. Engl. J. Med.. 2015 May;372(20):1964-5.

 

Last Updated: 14 May 2015

Go To URL
Functional TP53 mutations have no impact on response to cytotoxic agents in metastatic colon cancer.
 

Author(s): Jeanne Netter, Jacqueline Lehmann-Che, Jerome Lambert, Anne Tallet, Nelson Lourenco, Hany Soliman, Philippe Bertheau, Benjamin Pariente, Mircea Chirica, Marc Pocard, Matthieu Allez, Hugues De The, Jean-Marc Gornet

Journal: Bull Cancer. 2015 Feb;102(2):117-25.

 

Survival of metastatic colon cancer (mCC) patients has considerably improved with optimization of new drugs regimen. Inactivation of TP53 pathway by TP53 mutations is observed in nearly half of colorectal tumors. The impact of such mutations has been poorly studied in the metastatic setting.

Last Updated: 27 Feb 2015

Go To URL
FOLFOXIRI and bevacizumab for metastatic colorectal cancer.
 

Author(s): Chiara Cremolini, Fotios Loupakis, Alfredo Falcone

Journal: N. Engl. J. Med.. 2015 Jan;372(3):291-2.

 

Last Updated: 15 Jan 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Metastatic cancer" returned 369 free, full-text review articles on human participants. First 3 results:

ACR Appropriateness Criteria® rectal cancer: metastatic disease at presentation.
 

Author(s): Karyn A Goodman, Sarah A Milgrom, Joseph M Herman, May Abdel-Wahab, Nilofer Azad, A William Blackstock, Prajnan Das, Theodore S Hong, Salma K Jabbour, William E Jones, Andre A Konski, Albert C Koong, Rachit Kumar, Miguel Rodriguez-Bigas, William Small, Charles R Thomas, W Warren Suh,

Journal: Oncology (Williston Park, N.Y.). 2014 Oct;28(10):867-71, 876, 878.

 

The management of rectal cancer in patients with metastatic disease at presentation is highly variable. There are no phase III trials addressing therapeutic approaches, and the optimal sequencing of chemotherapy, radiation therapy, and surgery remains unresolved. Although chemoradiation ...

Last Updated: 9 Dec 2014

Go To URL
[Clinical efficacy and safety of enzalutamide in metastatic castration-resistant prostate cancer: systematic review and meta-analysis].
 

Author(s): Valentin Brodszky, Márta Péntek, Petra Baji, Fanni Rencz, Lajos Géczi, Miklós Szûcs, Csaba Berczi, László Gulácsi

Journal: Magy Onkol. 2014 Sep;58(3):189-97.

 

Enzalutamide, abiraterone-acetate, and cabazitaxel are licensed post-docetaxel treatments of metastatic castration-resistant prostate cancer (mCRPC) in Hungary. The objectives of the study were to assess the efficacy and safety of post-docetaxel enzalutamide treatment and to compare ...

Last Updated: 27 Sep 2014

Go To URL
The AURORA initiative for metastatic breast cancer.
 

Author(s): D Zardavas, M Maetens, A Irrthum, T Goulioti, K Engelen, D Fumagalli, R Salgado, P Aftimos, K S Saini, C Sotiriou, P Campbell, P Dinh, G von Minckwitz, R D Gelber, M Dowsett, A Di Leo, D Cameron, J Baselga, M Gnant, A Goldhirsch, L Norton, M Piccart

Journal: Br. J. Cancer. 2014 Nov;111(10):1881-7.

 

Metastatic breast cancer is one of the leading causes of cancer-related mortality among women in the Western world. To date most research efforts have focused on the molecular analysis of the primary tumour to dissect the genotypes of the disease. However, accumulating evidence supports ...

Last Updated: 12 Nov 2014

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer
 

Status: Recruiting

Condition Summary: Metastatic Cancer; Metastatic Melanoma; Renal Cancer

 

Last Updated: 3 Apr 2015

Go to URL
CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer
 

Status: Recruiting

Condition Summary: Metastatic Cancer; Pancreatic Cancer; Mesothelioma; Ovarian

 

Last Updated: 4 Mar 2015

Go to URL

Last Updated: 20 Apr 2015

Go to URL